Marburg virus disease, Clinical syndrome An introduction to Ebola: the virus and the disease, Journal of Infectious Diseases, vol.179, issue.21, pp.1-9, 1971. ,
Isolation and partial characterization of a new virus causing acute haemorrhagic fever in Zaire, The Lancet, pp.309-569, 1977. ,
Outbreak of fatal illness among captive macaques in the Philippines caused by an Ebola-related filovirus, The American journal of tropical medicine and hygiene, pp.46-664, 1992. ,
Human Ebola Outbreak Resulting from Direct Exposure to Fruit Bats in Luebo, Democratic Republic of Congo, 2007, Vector-Borne and Zoonotic Diseases, vol.9, issue.6, pp.723-728, 2007. ,
DOI : 10.1089/vbz.2008.0167
URL : https://hal.archives-ouvertes.fr/hal-00399906
Evasion of Interferon Responses by Ebola and Marburg Viruses, Journal of Interferon & Cytokine Research, vol.29, issue.9, pp.511-520, 2009. ,
DOI : 10.1089/jir.2009.0076
Markedly Elevated Levels of Interferon (IFN)?????, IFN?????, Interleukin (IL)???2, IL???10, and Tumor Necrosis Factor????? Associated with Fatal Ebola Virus Infection, The Journal of Infectious Diseases, vol.179, issue.s1, pp.188-191, 1999. ,
DOI : 10.1086/514283
A highly immunogenic fragment derived from Zaire Ebola virus glycoprotein elicits effective neutralizing antibody, Virus research, pp.254-261, 2014. ,
Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPs, PLoS Medicine, vol.79, issue.6, p.177, 2006. ,
DOI : 10.1371/journal.pmed.0030177.sd001
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses, Nature Medicine, vol.179, issue.7, pp.11-786, 2005. ,
DOI : 10.1016/S0140-6736(82)91871-2
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial, The Lancet, vol.386, issue.9996, pp.386-857, 2015. ,
DOI : 10.1016/S0140-6736(15)61117-5
Outbreak of Marburg virus disease in Johannesburg, British Medical Journal, vol.13, issue.45995, pp.489-493, 1975. ,
Marburg-virus disease in Kenya, The Lancet, pp.319-816, 1982. ,
Characterization of a new Marburg virus isolated from a, pp.101-114, 1987. ,
Marburg Hemorrhagic Fever in Durba and Watsa, Democratic Republic of the Congo: Clinical Documentation, Features of Illness, and Treatment, The Journal of Infectious Diseases, vol.196, issue.s2, pp.148-153, 2007. ,
DOI : 10.1086/520543
Ebola hemorrhagic fever in Zaire, Bulletin of the World Health Organization, vol.56, issue.2, pp.271-293, 1976. ,
Ebola hemorrhagic fever in Sudan, Bulletin of the World Health Organization, vol.56, issue.2, pp.247-270, 1976. ,
Ebola haemorrhagic fever, The Lancet, pp.849-862, 2011. ,
Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread, Bulletin of the World Health Organization, issue.6, pp.61-997, 1983. ,
Preliminary report: isolation of Ebola virus from monkeys imported to USA, The Lancet, vol.335, issue.8688, pp.335-502, 1990. ,
DOI : 10.1016/0140-6736(90)90737-P
Reston ebolavirus in Humans and Animals in the Philippines: A Review, Journal of Infectious Diseases, vol.204, issue.suppl 3, pp.757-760, 2011. ,
DOI : 10.1093/infdis/jir296
Ebola Reston Virus Infection of Pigs: Clinical Significance and Transmission Potential, Journal of Infectious Diseases, vol.204, issue.suppl 3, pp.804-809, 2011. ,
DOI : 10.1093/infdis/jir300
Ebola Virus Outbreak among Wild Chimpanzees Living in a Rain Forest of Cote d'Ivoire, The Journal of Infectious Diseases, vol.179, issue.s1, pp.120-126, 1999. ,
DOI : 10.1086/514296
Human Infection Due to Ebola Virus, Subtype C??te d'Ivoire: Clinical and Biologic Presentation, The Journal of Infectious Diseases, vol.179, issue.s1, pp.48-53, 1999. ,
DOI : 10.1086/514285
The Reemergence of Ebola Hemorrhagic Fever, Democratic Republic of the Congo, 1995, The Journal of Infectious Diseases, vol.179, issue.s1, pp.76-86, 1995. ,
DOI : 10.1086/514306
Ebola Hemorrhagic Fever Outbreaks in Gabon, 1994???1997: Epidemiologic and Health Control Issues, The Journal of Infectious Diseases, vol.179, issue.s1, pp.65-75, 1994. ,
DOI : 10.1086/514290
Re-emergence of ebola haemorragic fever in Gabon, Lancet, issue.9307, pp.359-712, 2002. ,
The natural history of Ebola virus in Africa, Microbes and Infection, vol.7, issue.7-8, pp.1005-1014, 2005. ,
DOI : 10.1016/j.micinf.2005.04.006
Clinical Manifestations and Case Management of Ebola Haemorrhagic Fever Caused by a Newly Identified Virus Strain, Emerging Infectious Disease, pp.52986-2011, 2007. ,
Genomic analysis of filoviruses associated with four viral hemorrhagic fever outbreaks in Uganda and the Democratic Republic of the Congo in 2012, Virology, vol.442, issue.2, pp.442-97, 2013. ,
DOI : 10.1016/j.virol.2013.04.014
Discovery of an Ebolavirus-Like Filovirus in Europe, PLoS Pathogens, vol.7, issue.10, pp.1002304-1002351, 2011. ,
DOI : 10.1371/journal.ppat.1002304.s005
Discussions and decisions of the 2012???2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012???June 2013, Discussions and decisions of the 2012?2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, pp.821-830, 2012. ,
DOI : 10.1007/s00705-013-1846-9
Public Health Image Library, 1832. ,
Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus, Virus research, vol.29, issue.3, pp.215-240, 1993. ,
Descriptive analysis of Ebola virus proteins, Virology, vol.147, issue.1, pp.169-176, 1985. ,
DOI : 10.1016/0042-6822(85)90236-3
Processing of the Ebola virus glycoprotein by the proprotein convertase furin, Proceedings of the National Academy of Sciences, pp.95-5762, 1998. ,
DOI : 10.1073/pnas.95.10.5762
Crystal Structure of the Ebola Virus Membrane Fusion Subunit, GP2, from the Envelope Glycoprotein Ectodomain, Molecular Cell, vol.2, issue.5, pp.605-616, 1998. ,
DOI : 10.1016/S1097-2765(00)80159-8
Ebola Virus Entry: A Curious and Complex Series of Events, PLOS Pathogens, vol.344, issue.9, p.1004731, 2005. ,
DOI : 10.1371/journal.ppat.1004731.g003
The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing., Proceedings of the National Academy of Sciences, pp.93-3602, 1996. ,
DOI : 10.1073/pnas.93.8.3602
Ctype lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans, Journal of virology, issue.13, pp.76-6841, 2002. ,
Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses, Journal of General Virology, vol.81, issue.9, pp.81-2155, 2000. ,
DOI : 10.1099/0022-1317-81-9-2155
Ebola Virus Glycoprotein Toxicity Is Mediated by a Dynamin-Dependent Protein-Trafficking Pathway, Journal of Virology, vol.79, issue.1, pp.547-553, 2005. ,
DOI : 10.1128/JVI.79.1.547-553.2005
Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level, Journal of General Virology, vol.87, issue.5, pp.1247-1257, 2006. ,
DOI : 10.1099/vir.0.81361-0
Shedding of Ebola Virus Surface Glycoprotein Is a Mechanism of Self-regulation of Cellular Cytotoxicity and Has a Direct Effect on Virus Infectivity, Journal of Infectious Diseases, vol.212, issue.suppl 2, p.268, 2015. ,
DOI : 10.1093/infdis/jiv268
Immunization for Ebola virus infection, Nature Medicine, vol.3, issue.1, pp.37-42, 1998. ,
DOI : 10.1038/sj.gt.3300403
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults, Vaccine, vol.29, issue.2, pp.29-304, 2010. ,
DOI : 10.1016/j.vaccine.2010.10.037
Properties of Replication-Competent Vesicular Stomatitis Virus Vectors Expressing Glycoproteins of Filoviruses and Arenaviruses, Journal of Virology, vol.78, issue.10, pp.78-5458, 2004. ,
DOI : 10.1128/JVI.78.10.5458-5465.2004
Ebolavirus Glycoprotein GP Masks both Its Own Epitopes and the Presence of Cellular Surface Proteins, Journal of Virology, vol.83, issue.18, pp.83-9596, 2009. ,
DOI : 10.1128/JVI.00784-09
Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses, The FASEB Journal, vol.20, issue.14, pp.20-2519, 2006. ,
DOI : 10.1096/fj.06-6151com
Ebola Virus Glycoprotein: Proteolytic Processing, Acylation, Cell Tropism, and Detection of Neutralizing Antibodies, Journal of Virology, vol.75, issue.3, pp.75-1576, 2001. ,
DOI : 10.1128/JVI.75.3.1576-1580.2001
Antigenic Subversion: A Novel Mechanism of Host Immune Evasion by Ebola Virus, PLoS Pathogens, vol.422, issue.3, p.1003065, 2012. ,
DOI : 10.1371/journal.ppat.1003065.s005
The multiple roles of sGP in Ebola pathogenesis, Viral Immunology, vol.28, issue.1, pp.3-9, 2015. ,
Effects of Ebola Virus Glycoproteins on Endothelial Cell Activation and Barrier Function, Journal of Virology, vol.79, issue.16, pp.79-10442, 2005. ,
DOI : 10.1128/JVI.79.16.10442-10450.2005
sGP Serves as a Structural Protein in Ebola Virus Infection, Journal of Infectious Diseases, vol.204, issue.suppl 3, pp.897-903, 2011. ,
DOI : 10.1093/infdis/jir313
Evidence against Ebola Virus sGP Binding to Human Neutrophils by a Specific Receptor, Virology, vol.303, issue.1, pp.9-14, 2002. ,
DOI : 10.1006/viro.2002.1715
Ebolavirus evolution: past and present, PLoS Pathogens, issue.11, pp.11-1005221, 2015. ,
Molecular Determinants of Ebola Virus Virulence in Mice, PLoS Pathogen, p.73, 2006. ,
DOI : 1098-5514(2001)075[5205:EVVPFA]2.0.CO;2
VP24 Is a Molecular Determinant of Ebola Virus Virulence in Guinea Pigs, Journal of Infectious Diseases, vol.204, issue.suppl 3, pp.1011-1020, 2011. ,
DOI : 10.1093/infdis/jir338
Estimating the Reproduction Number of Ebola Virus (EBOV) During the 2014 Outbreak in West Africa, PLoS Currents, vol.6, 2014. ,
DOI : 10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288
L'entrée du virus Ébola et Marburg : interaction entre la glycoprotéine virale et les facteurs cellulaires, John Libbey Eurotext, vol.16, issue.3, pp.168-177, 2012. ,
Characterization of Ebola Virus Entry by Using Pseudotyped Viruses: Identification of Receptor-Deficient Cell Lines, Journal of Virology, vol.72, issue.4, pp.3155-3160, 1998. ,
Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses, The Journal of Pathology, vol.345, issue.2, pp.153-174, 2015. ,
DOI : 10.1002/path.4456
DC-SIGN and DC-SIGNR Bind Ebola Glycoproteins and Enhance Infection of Macrophages and Endothelial Cells, Virology, vol.305, issue.1, pp.305-115, 2003. ,
DOI : 10.1006/viro.2002.1730
Tyro3 Family-Mediated Cell Entry of Ebola and Marburg Viruses, Journal of Virology, vol.80, issue.20, pp.80-10109, 2006. ,
DOI : 10.1128/JVI.01157-06
Folate Receptor-?? Is a Cofactor for Cellular Entry by Marburg and Ebola Viruses, Cell, vol.106, issue.1, pp.117-126, 2001. ,
DOI : 10.1016/S0092-8674(01)00418-4
Ebola virus uses clathrin-mediated endocytosis as an entry pathway, Virology, vol.401, issue.1, pp.401-419, 2010. ,
DOI : 10.1016/j.virol.2010.02.015
Association of the Caveola Vesicular System with Cellular Entry by Filoviruses, Journal of Virology, vol.76, issue.10, pp.76-5266, 2002. ,
DOI : 10.1128/JVI.76.10.5266-5270.2002
Ebolavirus Is Internalized into Host Cells via Macropinocytosis in a Viral Glycoprotein-Dependent Manner, PLoS Pathogens, vol.282, issue.9, pp.1001121-96, 2008. ,
DOI : 10.1371/journal.ppat.1001121.s027
Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein, Virology, vol.415, issue.2, pp.415-83, 2011. ,
DOI : 10.1016/j.virol.2011.04.002
Role of the Phosphatidylserine Receptor TIM-1 in Enveloped-Virus Entry, Journal of Virology, vol.87, issue.15, pp.8327-8341, 2013. ,
DOI : 10.1128/JVI.01025-13
Role of Endosomal Cathepsins in Entry Mediated by the Ebola Virus Glycoprotein, Journal of Virology, vol.80, issue.8, pp.80-4174, 2006. ,
DOI : 10.1128/JVI.80.8.4174-4178.2006
Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection, Science, vol.308, issue.5728, pp.308-1643, 2005. ,
DOI : 10.1126/science.1110656
Ebola virus entry requires the cholesterol transporter Niemann???Pick C1, Nature, vol.107, issue.7364, pp.477-340, 2011. ,
DOI : 10.1038/nature10348
Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection, Nature, vol.103, issue.7364, pp.477-344, 2011. ,
Lassa virus entry requires a trigger-induced receptor switch, Science, vol.344, issue.6191, pp.344-1506, 2014. ,
DOI : 10.1126/science.1252480
Structure and function of the complete internal fusion loop from Ebolavirus glycoprotein 2, Proceedings of the National Academy of Science of the USA, pp.11211-11216, 2011. ,
DOI : 10.1073/pnas.1104760108
Phosphorylation of Ebola Virus VP30 Influences the Composition of the Viral Nucleocapsid Complex: IMPACT ON VIRAL TRANSCRIPTION AND REPLICATION, Journal of Biological Chemistry, vol.288, issue.16, pp.11165-11174, 2013. ,
DOI : 10.1074/jbc.M113.461285
Late budding domains and host proteins in enveloped virus release, Virology, vol.344, issue.1, pp.55-63, 2006. ,
DOI : 10.1016/j.virol.2005.09.044
HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress, Nature Medicine, vol.7, issue.12, pp.1313-1319, 2001. ,
DOI : 10.1038/nm1201-1313
Ebola Virus VP40 Drives the Formation of Virus-Like Filamentous Particles Along with GP, Journal of Virology, vol.76, issue.10, pp.76-4855, 2002. ,
DOI : 10.1128/JVI.76.10.4855-4865.2002
Ebola Virus Matrix Protein VP40 Interaction with Human Cellular Factors Tsg101 and Nedd4, Journal of Molecular Biology, vol.326, issue.2, pp.493-502, 2003. ,
DOI : 10.1016/S0022-2836(02)01406-7
URL : https://hal.archives-ouvertes.fr/hal-00313940
Single-Particle Tracking Demonstrates that Actin Coordinates the Movement of the Ebola Virus Matrix Protein, Biophysical Journal, vol.103, issue.9, pp.41-43, 2012. ,
DOI : 10.1016/j.bpj.2012.09.026
Marburg Virus Infection Detected in a Common African Bat, PLoS ONE, vol.303, issue.8, p.764, 2007. ,
DOI : 10.1371/journal.pone.0000764.t001
Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats, PLoS Pathogens, vol.179, issue.7, p.1000536, 2009. ,
DOI : 10.1371/journal.ppat.1000536.s001
Ecosystèmes forestiers et virus Ebola, Bull. Soc. Pathol. Exot, issue.3, pp.93-172, 2000. ,
Recent Common Ancestry of Ebola Zaire Virus Found in a Bat Reservoir, PLoS Pathogens, vol.2, issue.10, 2006. ,
DOI : 1080-6040(1996)002[0321:EIOPAA]2.0.CO;2
Identification of Ebola virus sequences present as RNA or DNA in organs of terrestrial small mammals of the Central African Republic, Microbes and infection, pp.1193-1201, 1999. ,
A non-retroviral RNA virus persists in DNA form, Nature, issue.6657, pp.390-298, 1997. ,
Filoviruses are ancient and integrated into mammalian genomes, BMC Evolutionary Biology, vol.10, issue.1, p.193, 2010. ,
DOI : 10.1186/1471-2148-10-193
Les chauves-souris, réservoirs du virus Ebola: Le mystère se dissipe, M/S: médecine sciences, pp.78-79, 2006. ,
DOI : 10.1051/medsci/200622178
URL : http://www.erudit.org/revue/ms/2006/v22/n1/012237ar.pdf
Assessment of the Risk of Ebola Virus Transmission from Bodily Fluids and Fomites, The Journal of Infectious Diseases, vol.196, issue.s2, pp.142-147, 2007. ,
DOI : 10.1086/520545
Social Pathways for Ebola Virus Disease in Rural Sierra Leone, and Some Implications for Containment, PLOS Neglected Tropical Diseases, vol.371, issue.440, p.3567, 2015. ,
DOI : 10.1371/journal.pntd.0003567.s007
Ebola virus as a sexually transmitted infection, Current opinion in infectious diseases, pp.83-85, 2015. ,
Persistence of Ebola Virus in Ocular Fluid during Convalescence, New England Journal of Medicine, vol.372, issue.25, pp.372-2423, 2015. ,
DOI : 10.1056/NEJMoa1500306
Short report: lack of virus replication in arthropods after intrathoracic inoculation of Ebola Reston virus, The American journal of tropical medicine and hygiene, pp.89-90, 1996. ,
Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus, International journal of experimental pathology, vol.132, issue.764, p.227, 1995. ,
Ecologie des Ebolavirus: http://www.cdc.gov/vhf/ebola/resources/virus-ecology-fr.html The origin and evolution of Ebola and Marburg viruses, Molecular Biology and Evolution, vol.134, issue.8, pp.14-800, 1997. ,
Evolutionary history of Ebola virus, Epidemiology and Infection, vol.56, issue.06, pp.1138-1145, 2014. ,
DOI : 10.1371/journal.pone.0021740
Persistence and Genetic Stability of Ebola Virus during the Outbreak in Kikwit, Democratic Republic of the Congo, 1995, The Journal of Infectious Diseases, vol.179, issue.s1, pp.170-176, 1995. ,
DOI : 10.1086/514291
Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak, Science, issue.6202, pp.345-1369, 2014. ,
Basic Clinical and Laboratory Features of Filoviral Hemorrhagic Fever, Journal of Infectious Diseases, vol.204, issue.suppl 3, pp.810-816, 2011. ,
DOI : 10.1093/infdis/jir299
Ebola Hemorrhagic Fever in Kikwit, Democratic Republic of the Congo: Clinical Observations in 103 Patients, The Journal of Infectious Diseases, vol.179, issue.s1, pp.1-7, 1999. ,
DOI : 10.1086/514308
Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever, The international journal of biochemistry & cell biology, pp.37-1560, 2005. ,
Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques, The American Journal of Pathology, vol.163, issue.6, pp.2347-2370, 2003. ,
DOI : 10.1016/S0002-9440(10)63591-2
Molecular mechanisms of Ebola virus pathogenesis: focus on cell death, Cell Death and Differentiation, vol.824, issue.8, pp.22-1250, 2015. ,
DOI : 10.1371/journal.pone.0051548
Pathogenesis of filoviral haemorrhagic fevers, The Lancet infectious diseases, pp.487-498, 2004. ,
Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus, Nature Reviews Microbiology, vol.344, issue.11, pp.13-663, 2015. ,
DOI : 10.1038/nrmicro3524
Human Fatal Zaire Ebola Virus Infection Is Associated with an Aberrant Innate Immunity and with Massive Lymphocyte Apoptosis, PLoS Neglected Tropical Diseases, vol.20, issue.10, p.837, 2010. ,
DOI : 10.1371/journal.pntd.0000837.s002
Pathogenesis of Ebola Hemorrhagic Fever in Primate Models, The American Journal of Pathology, vol.163, issue.6, p.2371, 2003. ,
DOI : 10.1016/S0002-9440(10)63592-4
Diagnosis of Ebola haemorrhagic fever by RT?PCR in an epidemic setting, Journal of medical virology, vol.151, issue.604, pp.463-467, 2000. ,
Multiplex real-time PCR method for rapid detection of Marburg virus and Ebola virus, Chinese journal of experimental and clinical virology, vol.26, issue.4, pp.313-315, 2012. ,
Rapid Diagnosis of Ebola Hemorrhagic Fever by Reverse Transcription-PCR in an Outbreak Setting and Assessment of Patient Viral Load as a Predictor of Outcome, Journal of Virology, vol.78, issue.8, pp.78-4330, 2004. ,
DOI : 10.1128/JVI.78.8.4330-4341.2004
ELISA for the Detection of Antibodies to Ebola Viruses, The Journal of Infectious Diseases, vol.179, issue.s1, pp.192-198, 1999. ,
DOI : 10.1086/514313
Ebola, le test Ezyscreen fait ses preuves sur le terrain: http://www.inserm.fr/espace-journalistes/diagnostic-rapide-d-ebola-le-test-ezyscreen-r-fait- ses-preuves-sur-le-terrain ,
Rapid and simple detection of Ebola virus by reverse transcription-loopmediated isothermal amplification, Journal of virological methods, vol.141, issue.1, pp.78-83, 2007. ,
A case of Ebola virus infection., BMJ, vol.2, issue.6086, pp.541-544, 1977. ,
DOI : 10.1136/bmj.2.6086.541
Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent Patients, The Journal of Infectious Diseases, vol.179, issue.s1, pp.18-23, 1999. ,
DOI : 10.1086/514298
Ebola Hemorrhagic Fever, Democratic Republic of the Congo, 1995: Determinants of Survival, The Journal of Infectious Diseases, vol.179, issue.s1, pp.24-27, 1999. ,
DOI : 10.1086/514311
Ebola Hemorrhagic Fever: Evaluation of Passive Immunotherapy in Nonhuman Primates, The Journal of Infectious Diseases, vol.196, issue.s2, pp.400-403, 2007. ,
DOI : 10.1086/520587
Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea, New England Journal of Medicine, vol.374, issue.1, pp.33-42, 2016. ,
DOI : 10.1056/NEJMoa1511812
URL : https://hal.archives-ouvertes.fr/hal-01252702
Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients, Nature Medicine, vol.5, issue.4, pp.423-426, 1999. ,
DOI : 10.1038/7422
Development and study of the properties of immunoglobulin against Ebola fever, Voprosy Virusologii, issue.6, pp.40-270, 1995. ,
Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses, Archives of virology, vol.11, issue.2, pp.135-140, 1996. ,
DOI : 10.1007/978-3-7091-7482-1_12
Preparation and Use of Hyperimmune Serum for Prophylaxis and Therapy of Ebola Virus Infections, The Journal of Infectious Diseases, vol.179, issue.s1, pp.218-223, 1999. ,
DOI : 10.1086/514294
Post exposure antibody prophylaxis protects nonhuman primates from filovirus disease, Proceedings of the National Academy of Sciences of the United States of America, pp.5034-5039, 2012. ,
Pre- and Postexposure Prophylaxis of Ebola Virus Infection in an Animal Model by Passive Transfer of a Neutralizing Human Antibody, Journal of Virology, vol.76, issue.12, pp.6408-6412, 2002. ,
DOI : 10.1128/JVI.76.12.6408-6412.2002
Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys, PLoS Pathogens, vol.141, issue.1, 2007. ,
DOI : 1537-6613(1980)141[0580:LVIORM]2.0.CO;2
Successful treatment of Ebola virusinfected cynomolgus macaques with monoclonal antibodies Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb, Science Translational Medicine, vol.4178, issue.3, pp.138-81, 2012. ,
Monoclonal antibodies combined with adenovirus-vectored interferon significantly extend the treatment window in Ebola virusinfected guinea pigs, Journal of Virology, vol.87, issue.13, pp.7754-7757, 2013. ,
Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques, Proceedings of the National Academy of Sciences of the United States of America, pp.18030-18035, 2012. ,
DOI : 10.1073/pnas.1213709109
Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail, Science Translational Medicine, vol.5, issue.199, pp.199-113, 0199. ,
DOI : 10.1126/scitranslmed.3006608
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp, Nature, vol.27, issue.7520, pp.514-561, 2014. ,
DOI : 10.1086/514305
Fighting Ebola with ZMapp: spotlight on plant-made antibody, Science China Life Sciences, issue.10, pp.57-987, 2014. ,
Structures of protective antibodies reveal sites of vulnerability on Ebola virus, Current Issue, pp.111-17182, 2014. ,
T-705), a novel viral RNA polymerase inhibitor, Antiviral research, vol.100, issue.2, pp.446-454 ,
Evaluation of different strategies for post-exposure treatment of Ebola virus infection in rodents, 2011. ,
Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model, Antiviral Research, vol.105, pp.17-21, 2014. ,
DOI : 10.1016/j.antiviral.2014.02.014
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea, PLOS Medicine, vol.27, issue.1, p.1001967, 2016. ,
DOI : 10.1371/journal.pmed.1001967.s011
URL : https://hal.archives-ouvertes.fr/hal-01327168
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430, Nature, vol.47, issue.7496, pp.508-402, 2014. ,
DOI : 10.1038/nature13027
Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions causes by dsDNA viruses, Expert Review of Antiinfective Therapy, issue.10, pp.12-1171, 2014. ,
Postexposure Protection of Guinea Pigs against a Lethal Ebola Virus Challenge Is Conferred by RNA Interference, The Journal of Infectious Diseases, vol.193, issue.12, pp.1650-1657, 2007. ,
DOI : 10.1086/504267
Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study, The Lancet, vol.375, issue.9729, pp.1896-1905, 2010. ,
DOI : 10.1016/S0140-6736(10)60357-1
Gene-Specific Countermeasures against Ebola Virus Based on Antisense Phosphorodiamidate Morpholino Oligomers, PLoS Pathogens, vol.175, issue.1, p.1, 2006. ,
DOI : 0022-1767(2005)175[1184:IOHACT]2.0.CO;2
Advanced antisense therapies for postexposure protection against lethal filovirus infections, Nature Medicine, vol.251, issue.9, pp.991-994, 2010. ,
DOI : 10.1038/nm.2202
Discovery and Early Development of AVI-7537 and AVI-7288 for the Treatment of Ebola Virus and Marburg Virus Infections, Viruses, vol.4, issue.12, pp.2806-2830, 2012. ,
DOI : 10.3390/v4112806
FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection Treatment of Ebola virus infection with a recombinant inhibitor of factor VII/tissue factor: a study in rhesus monkeys, Science Translational Medicine Lancet, vol.5, issue.362, pp.190-79, 2003. ,
Recombinant Human Activated Protein C for the Postexposure Treatment of Ebola Hemorrhagic Fever, The Journal of Infectious Diseases, vol.196, issue.s2, pp.390-399, 2007. ,
DOI : 10.1086/520598
Camouflage and Misdirection: The Full-On Assault of Ebola Virus Disease, Cell, vol.159, issue.3, pp.477-486, 2014. ,
DOI : 10.1016/j.cell.2014.10.006
Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I Signaling, Journal of Virology, vol.80, issue.11, pp.80-5168, 2006. ,
DOI : 10.1128/JVI.02199-05
The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3, Journal of Virology, vol.77, issue.14, pp.77-7945, 2003. ,
DOI : 10.1128/JVI.77.14.7945-7956.2003
Ebola virus VP24 binds karyopherin ?1 and blocks STAT1 nuclear accumulation, Journal of virology, issue.11, pp.80-5156, 2006. ,
The VP35 Protein of Ebola Virus Inhibits the Antiviral Effect Mediated by Double-Stranded RNA-Dependent Protein Kinase PKR, Journal of Virology, vol.81, issue.1, pp.182-192, 2007. ,
DOI : 10.1128/JVI.01006-06
Tetherinmediated restriction of filovirus budding is antagonized by the Ebola glycoprotein, Proceedings of the National Academy of Sciences, pp.2886-2891, 2009. ,
The Ebola Virus Glycoprotein and HIV-1 Vpu Employ Different Strategies to Counteract the Antiviral Factor Tetherin, Journal of Infectious Diseases, vol.204, issue.suppl 3, pp.850-860, 2011. ,
DOI : 10.1093/infdis/jir378
The Lack of Maturation of Ebola Virus-Infected Dendritic Cells Results from the Cooperative Effect of at Least Two Viral Domains, Journal of Virology, vol.87, issue.13, pp.7471-7485, 2013. ,
DOI : 10.1128/JVI.03316-12
Role of Natural Killer Cells in Innate Protection against Lethal Ebola Virus Infection, The Journal of Experimental Medicine, vol.162, issue.2, pp.169-179, 2004. ,
DOI : 10.1126/science.1060042
Robust and sustained immune activation in human Ebola virus infection: Fig. 1., Proceedings of the National Academy of Sciences, pp.4518-4519, 2015. ,
DOI : 10.1073/pnas.1503864112
Human Ebola virus infection results in substantial immune activation, Proceedings of the National Academy of Sciences, pp.112-4719, 2015. ,
DOI : 10.1073/pnas.1502619112
???????????????????????????????????????I??????????????????????????????????????????????????????????????????, Journal of Zhejiang University-SCIENCE B, vol.16, issue.1, pp.1-9, 2015. ,
DOI : 10.1631/jzus.B1400365
Human Fatal Zaire Ebola Virus Infection Is Associated with an Aberrant Innate Immunity and with Massive Lymphocyte Apoptosis, PLoS Neglected Tropical Diseases, vol.20, issue.10, p.837, 2010. ,
DOI : 10.1371/journal.pntd.0000837.s002
Human asymptomatic Ebola infection and strong inflammatory response, The Lancet, pp.355-2210, 2000. ,
Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance, Science, vol.346, issue.6212, pp.346-987, 2014. ,
DOI : 10.1126/science.1259595
Une immunité naturelle contre Ebola?, Actualité scientifique, 2010. ,
Recombinant Vesicular Stomatitis Virus-Based Vaccines Against Ebola and Marburg Virus Infections, Journal of Infectious Diseases, vol.204, issue.suppl 3, pp.1075-1081, 2011. ,
DOI : 10.1093/infdis/jir349
Understanding the host???pathogen interaction saves lives: lessons from vaccines and vaccinations, Current Opinion in Immunology, vol.36, pp.8-13, 2015. ,
DOI : 10.1016/j.coi.2015.04.003
Development of vaccines for prevention of Ebola virus infection, Microbes and Infection, vol.17, issue.2, pp.98-108, 2015. ,
DOI : 10.1016/j.micinf.2014.12.004
Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine, Current Opinion in Immunology, vol.35, pp.131-136, 2015. ,
DOI : 10.1016/j.coi.2015.06.006
Antigenicity and Vaccine Potential of Marburg Virus Glycoprotein Expressed by Baculovirus Recombinants, Virology, vol.239, issue.1, pp.239-206, 1997. ,
DOI : 10.1006/viro.1997.8883
Immunology of protection from Ebola virus infection, Science Translational Medicine, vol.7, issue.286, pp.286-297, 2015. ,
DOI : 10.1126/scitranslmed.aaa8202
Generation of biologically contained Ebola viruses, Proceedings of the National Academy of Sciences, pp.1129-1133, 2008. ,
DOI : 10.1073/pnas.0708057105
Replication-Deficient Ebolavirus as a Vaccine Candidate, Journal of Virology, vol.83, issue.8, pp.83-3810, 2009. ,
DOI : 10.1128/JVI.00074-09
An Ebola whole-virus vaccine is protective in nonhuman primates, Science, vol.348, issue.6233, pp.348-439, 2015. ,
DOI : 10.1126/science.aaa4919
Inactivated vaccine for Ebola virus efficacious in guineapig model, The Lancet, pp.316-1294, 1980. ,
Attempts to develop a vaccine against Ebola fever, Voprosy virusologii, issue.6, pp.40-257, 1994. ,
Evaluation in Nonhuman Primates of Vaccines against Ebola Virus, Perspectives), Emerging infectious diseases, pp.503-508, 2002. ,
DOI : 10.3201/eid0805.010284
Ebola Virus Inactivation with Preservation of Antigenic and Structural Integrity by a Photoinducible Alkylating Agent, The Journal of Infectious Diseases, vol.196, issue.s2, pp.276-283, 2007. ,
DOI : 10.1086/520605
Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs, Virus Research, vol.92, issue.2, pp.187-193, 2003. ,
DOI : 10.1016/S0168-1702(02)00338-6
Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice, Vaccine, vol.29, issue.16, pp.29-2968, 2011. ,
DOI : 10.1016/j.vaccine.2011.01.113
Virus-like particles as immunogens, Trends in Microbiology, vol.11, issue.9, pp.438-444, 2003. ,
DOI : 10.1016/S0966-842X(03)00208-7
Ebola Virus VP40 Drives the Formation of Virus-Like Filamentous Particles Along with GP, Journal of Virology, vol.76, issue.10, pp.76-4855, 2002. ,
DOI : 10.1128/JVI.76.10.4855-4865.2002
Ebola virus-like particles protect from lethal Ebola virus infection, Proceedings of the National Academy of Sciences, pp.15889-15894, 2003. ,
DOI : 10.1073/pnas.2237038100
Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies, Virology, vol.351, issue.2, pp.351-260, 2006. ,
DOI : 10.1016/j.virol.2006.03.021
Induction of Humoral and CD8+ T Cell Responses Are Required for Protection against Lethal Ebola Virus Infection, The Journal of Immunology, vol.175, issue.2, pp.1184-1191, 2005. ,
DOI : 10.4049/jimmunol.175.2.1184
Filovirus-like particles as vaccines and discovery tools, Expert review of vaccines, pp.429-440, 2005. ,
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections, Vaccine, vol.23, issue.23, pp.23-3033, 2005. ,
DOI : 10.1016/j.vaccine.2004.11.070
Filovirus???Like Particles Produced in Insect Cells: Immunogenicity and Protection in Rodents, The Journal of Infectious Diseases, vol.196, issue.s2, pp.421-429, 2007. ,
DOI : 10.1086/520612
L'apport des nouvelles technologies en vaccinologie, médecine/sciences, pp.386-90, 2007. ,
Genetic immunization is a simple method for eliciting an immune
response, Nature, vol.356, issue.6365, pp.356-152, 1992. ,
DOI : 10.1038/356152a0
DNA vaccines: Successes and limitations in cancer and infectious disease, Journal of Cellular Biochemistry, vol.201, issue.2, pp.235-242, 2006. ,
DOI : 10.1002/jcb.20775
Development of a preventive vaccine for Ebola virus infection in primates, Nature, issue.6812, pp.408-605, 2000. ,
Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species, PLoS Pathogens, vol.4, issue.5, p.1000904, 2010. ,
DOI : 10.1371/journal.ppat.1000904.g004
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial, The Lancet, vol.385, issue.9977, pp.385-1545, 2015. ,
DOI : 10.1016/S0140-6736(14)62385-0
Les vecteurs viraux: outils modernes de vaccination, pp.127-126, 2008. ,
Viral vectors for vaccine applications, Clinical and experimental vaccine research, pp.97-105, 2013. ,
Protective Cytotoxic T-Cell Responses Induced by Venezuelan Equine Encephalitis Virus Replicons Expressing Ebola Virus Proteins, Journal of Virology, vol.79, issue.22, pp.79-14189, 2005. ,
DOI : 10.1128/JVI.79.22.14189-14196.2005
Marburg Virus Vaccines Based upon Alphavirus Replicons Protect Guinea Pigs and Nonhuman Primates, Virology, vol.251, issue.1, pp.251-279, 1998. ,
DOI : 10.1006/viro.1998.9367
Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Protects Nonhuman Primates from Intramuscular and Aerosol Challenge with Ebolavirus, Journal of Virology, vol.87, issue.9, pp.4952-4964, 2013. ,
DOI : 10.1128/JVI.03361-12
Kunjin Virus Replicon-Based Vaccines Expressing Ebola Virus Glycoprotein GP Protect the Guinea Pig Against Lethal Ebola Virus Infection, Journal of Infectious Diseases, vol.204, issue.suppl 3, pp.1060-1065, 2011. ,
DOI : 10.1093/infdis/jir347
A Single Intranasal Inoculation with a Paramyxovirus-Vectored Vaccine Protects Guinea Pigs against a Lethal-Dose Ebola Virus Challenge, Journal of Virology, vol.80, issue.5, pp.2267-2279, 2006. ,
DOI : 10.1128/JVI.80.5.2267-2279.2006
Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic, Virology, vol.399, issue.2, pp.399-290, 2010. ,
DOI : 10.1016/j.virol.2010.01.015
Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response, Vaccine, vol.29, issue.1, pp.29-46, 2010. ,
DOI : 10.1016/j.vaccine.2010.10.024
Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses, Journal of Virology, vol.85, issue.20, pp.85-10605, 2011. ,
DOI : 10.1128/JVI.00558-11
Study of immunobiological properties of Ebola virus VP24 protein expressed by recombinant vaccinia virus, Voprosy Virusologii, vol.42, pp.115-120, 1997. ,
A Replicating Cytomegalovirus-Based Vaccine Encoding a Single Ebola Virus Nucleoprotein CTL Epitope Confers Protection against Ebola Virus, PLoS Neglected Tropical Diseases, vol.90, issue.Pt 2, p.1275, 2011. ,
DOI : 10.1371/journal.pntd.0001275.s004
A cytomegalovirus-based vaccine provides long-lasting protection against lethal Ebola virus challenge after a single dose, Vaccine, vol.33, issue.19, pp.33-2261, 2015. ,
DOI : 10.1016/j.vaccine.2015.03.029
Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection, Scientific Reports, vol.4, issue.1, 2016. ,
DOI : 10.1371/journal.pone.0005547
Adenoviruses as vaccine vectors, Molecular Therapy, vol.10, issue.4, pp.616-629, 2004. ,
DOI : 10.1016/j.ymthe.2004.07.013
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates, Nature, vol.424, issue.6949, pp.424-681, 2003. ,
DOI : 10.1038/nature01876
Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector, Clinical and Vaccine Immunology, pp.572-581, 2010. ,
Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections, Clinical and vaccine immunology, pp.460-467, 2008. ,
Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates, Science translational medicine Nature medicine, vol.4, issue.179, pp.158-146, 2011. ,
Effect of Preexisting Immunity to Adenovirus Human Serotype 5 Antigens on the Immune Responses of Nonhuman Primates to Vaccine Regimens Based on Human- or Chimpanzee-Derived Adenovirus Vectors, Journal of Virology, vol.81, issue.12, pp.81-6594, 2007. ,
DOI : 10.1128/JVI.02497-06
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial, The Lancet, vol.385, issue.9984, pp.385-2272, 2015. ,
DOI : 10.1016/S0140-6736(15)60553-0
Mucosal Delivery of Adenovirus???Based Vaccine Protects against Ebola Virus Infection in Mice, The Journal of Infectious Diseases, vol.196, issue.s2, pp.413-420, 2007. ,
DOI : 10.1086/520603
Airway Delivery of an Adenovirus-Based Ebola Virus Vaccine Bypasses Existing Immunity to Homologous Adenovirus in Nonhuman Primates, Journal of Virology, vol.87, issue.7, pp.3668-3677, 2013. ,
DOI : 10.1128/JVI.02864-12
Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge, Journal of Virology, vol.85, issue.9, pp.4222-4233, 2011. ,
DOI : 10.1128/JVI.02407-10
Chimpanzee adenovirus vaccine protects against Zaire Ebola virus, Virology, vol.346, issue.2, pp.346-394, 2006. ,
DOI : 10.1016/j.virol.2005.10.042
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge, Nature Medicine, vol.7, 2014. ,
DOI : 10.1038/nm.3702
Chimpanzee adenovirus vector Ebola vaccine? preliminary report, The New England journal of medicine, vol.373, issue.8, pp.775-776, 2015. ,
A monovalent chimpanzee adenovirus Ebola vaccine?preliminary report, 2015. ,
Vesicular Stomatitis Virus-Based Vaccines for Prophylaxis and Treatment of Filovirus Infections, Journal of Bioterrorism & Biodefense, vol.01, issue.01, 2011. ,
DOI : 10.4172/2157-2526.S1-004
Recombinant Vesicular Stomatitis Virus-Based Vaccines Against Ebola and Marburg Virus Infections, Journal of Infectious Diseases, vol.204, issue.suppl 3, pp.1075-1081, 2011. ,
DOI : 10.1093/infdis/jir349
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses, Nature Medicine, vol.179, issue.7, pp.11-786, 2005. ,
DOI : 10.1016/S0140-6736(82)91871-2
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses, Vaccine, vol.26, issue.52, pp.26-6894, 2008. ,
DOI : 10.1016/j.vaccine.2008.09.082
Mucosal Immunization of Cynomolgus Macaques with the VSV??G/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses, PLoS ONE, vol.79, issue.4, p.5547, 2009. ,
DOI : 10.1371/journal.pone.0005547.t001
Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates, PLoS ONE, vol.196, issue.4, p.94355, 2014. ,
DOI : 10.1371/journal.pone.0094355.s001
Effective Post-Exposure Treatment of Ebola Infection, PLoS Pathogens, vol.56, issue.1, p.2, 2007. ,
DOI : 10.1371/journal.ppat.0030002.sg002
Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman Primates, Journal of Virology, vol.82, issue.11, pp.82-5664, 2008. ,
DOI : 10.1128/JVI.00456-08
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment, The Lancet, vol.367, issue.9520, pp.367-1399, 2006. ,
DOI : 10.1016/S0140-6736(06)68546-2
VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain, Science, vol.349, issue.6249, pp.349-739, 2015. ,
DOI : 10.1126/science.aab3920
Prospects for immunisation against Marburg and Ebola viruses, Reviews in Medical Virology, vol.78, issue.Suppl 2, pp.344-357, 2010. ,
DOI : 10.1002/rmv.661
Single Immunization With a Monovalent Vesicular Stomatitis Virus-Based Vaccine Protects Nonhuman Primates Against Heterologous Challenge With Bundibugyo ebolavirus, Journal of Infectious Diseases, vol.204, issue.suppl 3, pp.1082-1089, 2011. ,
DOI : 10.1093/infdis/jir350
Vesicular Stomatitis Virus-Based Ebola Vaccines With Improved Cross-Protective Efficacy, Journal of Infectious Diseases, vol.204, issue.suppl 3, pp.1066-1074, 2011. ,
DOI : 10.1093/infdis/jir348
Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus, Journal of Virology, vol.83, issue.14, pp.83-7296, 2009. ,
DOI : 10.1128/JVI.00561-09
Neurovirulence properties of recombinant vesicular stomatitis virus vectors in nonhuman primates, Virology, issue.1, pp.360-396, 2007. ,
Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates, PLoS Neglected Tropical Diseases, vol.196, issue.3, p.1567, 2012. ,
DOI : 10.1371/journal.pntd.0001567.t004
Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates, PLoS Pathogens, vol.76, issue.9, p.1000225, 2008. ,
DOI : 10.1371/journal.ppat.1000225.t004
Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates, Proceedings of the National Academy of Sciences, pp.1893-1898, 2013. ,
DOI : 10.1073/pnas.1209591110
Phase 1 trials of rVSV Ebola vaccine in Africa and Europe?preliminary report, 2015. ,
A recombinant vesicular stomatitis virus Ebola vaccine?preliminary report, 2015. ,